What happens when you stop taking peptides?

When you stop taking a peptide, its effects fade as your body clears it, over days to weeks depending on its half-life, and the problem it was managing tends to return. The clearest evidence comes from weight-loss medicines. One year after people in the STEP 1 trial stopped semaglutide, they had regained, on average, about two-thirds of the weight they had lost. In SURMOUNT-4, people switched from tirzepatide to placebo regained an average of about 14% of their body weight over the next year, while those who stayed on it lost about 5.5% more. These medicines manage weight while you take them. They do not reset it for good. If you plan to stop, do it with your prescriber and a plan for keeping the results.

Weight loss sets off the body’s defenses. In a well-known study of people who lost weight by diet, hunger hormones shifted toward appetite and stayed shifted a year later. GLP-1 medicines counter part of that pressure while they are active. When the drug is gone, the pressure remains.

This is not a personal failure, and it is not unique to medication. The same biology makes regain common after diet-only weight loss. Our post on metabolic adaptation explains the mechanism in more detail.

Talk with your prescriber before stopping. Depending on your history and goals, the plan might be continuing at a maintenance dose, stepping down gradually, or stopping with closer follow-up. Stepping down gradually has not been well studied, so it is a decision to make with your prescriber. Resistance training and enough protein help protect muscle, and regular weigh-ins catch regain early, while it is still easy to act on.

For peptides used for other goals, the same rule applies: ask what is expected to change after you stop, and decide together how you will watch for it. Our medical weight loss program includes a maintenance strategy.

Checked October 30, 2026. Labels, guidelines and coverage rules change, so confirm anything that affects your care with your clinician or pharmacist.

• Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553-1564.
• Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331:38-48.
• Sumithran P, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365:1597-1604.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.

More from the Peptide Therapy FAQ: Does peptide therapy work? · How long does peptide therapy take to work? · Weight loss plateau after GLP-1 · GLP-1 medication comparison · Tirzepatide in Las Vegas

Educational information from LiveNow Longevity, not medical advice. It gives no doses and does not replace an evaluation by a licensed clinician who knows your history.